![]() |
|||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: TXNDC17 |
Gene summary for TXNDC17 |
![]() |
Gene information | Species | Human | Gene symbol | TXNDC17 | Gene ID | 84817 |
Gene name | thioredoxin domain containing 17 | |
Gene Alias | TRP14 | |
Cytomap | 17p13.1 | |
Gene Type | protein-coding | GO ID | GO:0007154 | UniProtAcc | A0A140VJY7 |
Top |
Malignant transformation analysis |
![]() |
![]() |
Entrez ID | Symbol | Replicates | Species | Organ | Tissue | Adj P-value | Log2FC | Malignancy |
84817 | TXNDC17 | GSM4909285 | Human | Breast | IDC | 2.24e-04 | 2.83e-01 | 0.21 |
84817 | TXNDC17 | GSM4909286 | Human | Breast | IDC | 2.76e-05 | -2.46e-01 | 0.1081 |
84817 | TXNDC17 | GSM4909290 | Human | Breast | IDC | 2.79e-12 | 5.14e-01 | 0.2096 |
84817 | TXNDC17 | GSM4909293 | Human | Breast | IDC | 3.25e-10 | 3.73e-01 | 0.1581 |
84817 | TXNDC17 | GSM4909294 | Human | Breast | IDC | 1.25e-24 | 6.30e-01 | 0.2022 |
84817 | TXNDC17 | GSM4909296 | Human | Breast | IDC | 6.44e-08 | -1.03e-02 | 0.1524 |
84817 | TXNDC17 | GSM4909297 | Human | Breast | IDC | 1.88e-12 | -6.69e-02 | 0.1517 |
84817 | TXNDC17 | GSM4909301 | Human | Breast | IDC | 1.29e-05 | 3.21e-01 | 0.1577 |
84817 | TXNDC17 | GSM4909302 | Human | Breast | IDC | 1.59e-02 | 2.03e-01 | 0.1545 |
84817 | TXNDC17 | GSM4909304 | Human | Breast | IDC | 2.54e-06 | 3.31e-01 | 0.1636 |
84817 | TXNDC17 | GSM4909306 | Human | Breast | IDC | 6.25e-03 | 3.33e-01 | 0.1564 |
84817 | TXNDC17 | GSM4909311 | Human | Breast | IDC | 6.53e-25 | -2.15e-01 | 0.1534 |
84817 | TXNDC17 | GSM4909312 | Human | Breast | IDC | 3.73e-07 | -1.54e-01 | 0.1552 |
84817 | TXNDC17 | GSM4909313 | Human | Breast | IDC | 3.47e-04 | -1.93e-03 | 0.0391 |
84817 | TXNDC17 | GSM4909315 | Human | Breast | IDC | 1.48e-22 | 6.84e-01 | 0.21 |
84817 | TXNDC17 | GSM4909316 | Human | Breast | IDC | 2.98e-17 | 6.89e-01 | 0.21 |
84817 | TXNDC17 | GSM4909317 | Human | Breast | IDC | 1.89e-04 | 3.34e-01 | 0.1355 |
84817 | TXNDC17 | GSM4909318 | Human | Breast | IDC | 1.40e-03 | 3.95e-01 | 0.2031 |
84817 | TXNDC17 | GSM4909319 | Human | Breast | IDC | 1.64e-37 | -2.71e-01 | 0.1563 |
84817 | TXNDC17 | GSM4909320 | Human | Breast | IDC | 5.18e-07 | 2.40e-02 | 0.1575 |
Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 |
![]() |
∗log2FC in expression of this searched gene in stem-like cells from each diseased tissue sample relative to stem-like cells in normal samples in each tissue plotted against the malignancy continuum. Samples are colored based on if they are from different disease stage. |
Top |
Malignant transformation related pathway analysis |
![]() |
![]() |
Tissue | Disease Stage | Enriched GO biological Processes |
Colorectum | AD | ![]() |
Colorectum | SER | ![]() |
Colorectum | MSS | ![]() |
Colorectum | MSI-H | ![]() |
Colorectum | FAP | ![]() |
∗Top 15 enriched GO BP terms are showed in the bar plot of each disease state in each tissue. Each row represents a significant GO biological process which is colored according to the -log10(p.adjust). |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
GO ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | Count |
GO:003461222 | Breast | DCIS | response to tumor necrosis factor | 33/1390 | 253/18723 | 1.11e-03 | 1.21e-02 | 33 |
GO:00332096 | Breast | DCIS | tumor necrosis factor-mediated signaling pathway | 15/1390 | 99/18723 | 6.21e-03 | 4.42e-02 | 15 |
GO:00988699 | Cervix | CC | cellular oxidant detoxification | 30/2311 | 101/18723 | 2.72e-06 | 7.93e-05 | 30 |
GO:00346129 | Cervix | CC | response to tumor necrosis factor | 55/2311 | 253/18723 | 1.75e-05 | 3.32e-04 | 55 |
GO:00713569 | Cervix | CC | cellular response to tumor necrosis factor | 51/2311 | 229/18723 | 1.75e-05 | 3.32e-04 | 51 |
GO:19907489 | Cervix | CC | cellular detoxification | 30/2311 | 116/18723 | 5.34e-05 | 7.94e-04 | 30 |
GO:00972379 | Cervix | CC | cellular response to toxic substance | 31/2311 | 124/18723 | 8.09e-05 | 1.10e-03 | 31 |
GO:00192213 | Cervix | CC | cytokine-mediated signaling pathway | 84/2311 | 472/18723 | 3.25e-04 | 3.44e-03 | 84 |
GO:00096369 | Cervix | CC | response to toxic substance | 52/2311 | 262/18723 | 3.34e-04 | 3.52e-03 | 52 |
GO:00987549 | Cervix | CC | detoxification | 33/2311 | 152/18723 | 7.97e-04 | 7.00e-03 | 33 |
GO:00332097 | Cervix | CC | tumor necrosis factor-mediated signaling pathway | 23/2311 | 99/18723 | 1.86e-03 | 1.38e-02 | 23 |
GO:000963624 | Cervix | N_HPV | response to toxic substance | 27/534 | 262/18723 | 9.00e-09 | 1.71e-06 | 27 |
GO:007135614 | Cervix | N_HPV | cellular response to tumor necrosis factor | 24/534 | 229/18723 | 4.38e-08 | 4.98e-06 | 24 |
GO:001922121 | Cervix | N_HPV | cytokine-mediated signaling pathway | 36/534 | 472/18723 | 9.30e-08 | 9.21e-06 | 36 |
GO:003461223 | Cervix | N_HPV | response to tumor necrosis factor | 24/534 | 253/18723 | 2.86e-07 | 2.13e-05 | 24 |
GO:009886924 | Cervix | N_HPV | cellular oxidant detoxification | 13/534 | 101/18723 | 5.89e-06 | 2.15e-04 | 13 |
GO:009723724 | Cervix | N_HPV | cellular response to toxic substance | 14/534 | 124/18723 | 1.22e-05 | 4.06e-04 | 14 |
GO:003320921 | Cervix | N_HPV | tumor necrosis factor-mediated signaling pathway | 12/534 | 99/18723 | 2.48e-05 | 6.77e-04 | 12 |
GO:199074824 | Cervix | N_HPV | cellular detoxification | 13/534 | 116/18723 | 2.69e-05 | 7.30e-04 | 13 |
GO:009875424 | Cervix | N_HPV | detoxification | 15/534 | 152/18723 | 3.05e-05 | 8.02e-04 | 15 |
Page: 1 2 3 4 5 6 7 8 9 |
![]() |
Pathway ID | Tissue | Disease Stage | Description | Gene Ratio | Bg Ratio | pvalue | p.adjust | qvalue | Count |
Page: 1 |
Top |
Cell-cell communication analysis |
![]() |
Ligand | Receptor | LRpair | Pathway | Tissue | Disease Stage |
Page: 1 |
Top |
Single-cell gene regulatory network inference analysis |
![]() |
TF | Cell Type | Tissue | Disease Stage | Target Gene | RSS | Regulon Activity |
∗The dot plots of a searched regulon are shown for all cell subpopulations in each disease state of each tissue based on the regulon specific score inferred using pySCENIC and by calculating the average expression. |
Page: 1 |
Top |
Somatic mutation of malignant transformation related genes |
![]() |
Hugo Symbol | Variant Class | Variant Classification | dbSNP RS | HGVSc | HGVSp | HGVSp Short | SWISSPROT | BIOTYPE | SIFT | PolyPhen | Tumor Sample Barcode | Tissue | Histology | Sex | Age | Stage | Therapy Types | Drugs | Outcome |
TXNDC17 | SNV | Missense_Mutation | rs751316876 | c.128G>A | p.Cys43Tyr | p.C43Y | Q9BRA2 | protein_coding | deleterious(0) | probably_damaging(1) | TCGA-D5-6930-01 | Colorectum | colon adenocarcinoma | Male | >=65 | I/II | Unknown | Unknown | SD |
TXNDC17 | insertion | Frame_Shift_Ins | rs753600817 | c.260dupA | p.Asn87LysfsTer12 | p.N87Kfs*12 | Q9BRA2 | protein_coding | TCGA-CM-5861-01 | Colorectum | colon adenocarcinoma | Female | <65 | I/II | Unknown | Unknown | PD | ||
TXNDC17 | SNV | Missense_Mutation | c.129N>G | p.Cys43Trp | p.C43W | Q9BRA2 | protein_coding | deleterious(0) | probably_damaging(1) | TCGA-BS-A0TA-01 | Endometrium | uterine corpus endometrioid carcinoma | Female | <65 | III/IV | Chemotherapy | taxol | PD | |
TXNDC17 | SNV | Missense_Mutation | novel | c.353N>G | p.Met118Arg | p.M118R | Q9BRA2 | protein_coding | deleterious(0) | possibly_damaging(0.83) | TCGA-DD-AAC8-01 | Liver | liver hepatocellular carcinoma | Male | >=65 | I/II | Unknown | Unknown | SD |
Page: 1 |
Top |
Related drugs of malignant transformation related genes |
![]() |
(DGIdb 4.0) |
Entrez ID | Symbol | Category | Interaction Types | Drug Claim Name | Drug Name | PMIDs |
Page: 1 |